The Prognostic and Predictive Role of Somatic

BRCA copy number variation genetic testing ovarian cancer

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
21 Mar 2021
Historique:
received: 26 02 2021
revised: 16 03 2021
accepted: 18 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 4 4 2021
Statut: epublish

Résumé

Previous research involving epithelial ovarian cancer patients showed that, compared to germline

Identifiants

pubmed: 33801055
pii: diagnostics11030565
doi: 10.3390/diagnostics11030565
pmc: PMC8003908
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

J Clin Oncol. 2012 Jul 20;30(21):2654-63
pubmed: 22711857
Front Oncol. 2020 Mar 10;10:295
pubmed: 32211327
J Clin Oncol. 2002 Jan 15;20(2):463-6
pubmed: 11786575
Cancer. 2003 May 1;97(9):2187-95
pubmed: 12712470
N Engl J Med. 2012 Apr 12;366(15):1382-92
pubmed: 22452356
Cancer Epidemiol Biomarkers Prev. 2001 Jul;10(7):733-41
pubmed: 11440958
PLoS One. 2017 Oct 20;12(10):e0186043
pubmed: 29053726
Nature. 2011 Jun 29;474(7353):609-15
pubmed: 21720365
JAMA. 2012 Jan 25;307(4):382-90
pubmed: 22274685
J Clin Oncol. 2010 Aug 1;28(22):3570-6
pubmed: 20606085
J Clin Oncol. 2016 May 1;34(13):1433-5
pubmed: 26976416
Cancer. 2005 Sep 1;104(5):1004-12
pubmed: 16047333
Nucleic Acids Res. 2010 Sep;38(16):e164
pubmed: 20601685
Genet Med. 2007 Mar;9(3):173-9
pubmed: 17413421
Genet Med. 2015 May;17(5):405-24
pubmed: 25741868
JAMA. 2011 Oct 12;306(14):1557-65
pubmed: 21990299
Oncotarget. 2017 Jul 4;8(27):43598-43599
pubmed: 28611314
J Clin Oncol. 2015 Jan 20;33(3):244-50
pubmed: 25366685
Eur J Cancer. 2004 Feb;40(3):422-8
pubmed: 14746861
PLoS One. 2013;8(3):e58182
pubmed: 23536787
J Clin Oncol. 2008 Jan 1;26(1):20-5
pubmed: 18165636
Bioinformatics. 2010 Aug 15;26(16):2069-70
pubmed: 20562413
Gynecol Oncol. 2017 Aug;146(2):217-224
pubmed: 28596016
Crit Rev Oncol Hematol. 2019 Aug;140:67-72
pubmed: 31176273
Cancer Res Treat. 2020 Apr;52(2):634-644
pubmed: 32019284
JAMA. 2000 May 3;283(17):2260-5
pubmed: 10807385
Minerva Med. 2019 Aug;110(4):301-319
pubmed: 31081309
Clin Cancer Res. 2008 Jun 15;14(12):3761-7
pubmed: 18559594
Lancet Oncol. 2014 Jul;15(8):852-61
pubmed: 24882434
Curr Opin Obstet Gynecol. 2015 Feb;27(1):23-33
pubmed: 25502425
Lancet Oncol. 2017 Sep;18(9):1274-1284
pubmed: 28754483
J Clin Oncol. 2010 Jun 1;28(16):2784-95
pubmed: 20404251
Ann Oncol. 2016 Aug;27(8):1449-55
pubmed: 27037296
Obstet Gynecol. 2010 May;115(5):945-952
pubmed: 20410767
Genome Med. 2009 Jun 16;1(6):62
pubmed: 19566914

Auteurs

Angela Toss (A)

Department of Oncology and Hematology, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy.
Department of Surgery, Medicine, Dentistry and Morphological Sciences with Transplant Surgery, Oncology and Regenerative Medicine Relevance, University of Modena and Reggio Emilia, 41124 Modena, Italy.

Claudia Piombino (C)

Department of Oncology and Hematology, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy.

Elena Tenedini (E)

Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy.

Alessandra Bologna (A)

Department of Oncology, Arcispedale S. Maria Nuova IRCCS, 42123 Reggio Emilia, Italy.

Elisa Gasparini (E)

Department of Oncology, Arcispedale S. Maria Nuova IRCCS, 42123 Reggio Emilia, Italy.

Vittoria Tarantino (V)

PhD Program in Clinical and Experimental Medicine, University of Modena and Reggio Emilia, 41124 Modena, Italy.

Maria Elisabetta Filieri (ME)

ASL Lecce, Polo Oncologico "Vito Fazzi", 73100 Lecce, Italy.

Luca Cottafavi (L)

Oncology Unit, Azienda Unità Sanitaria Locale di Modena, Ramazzini Hospital, 41012 Carpi, Italy.

Filippo Giovanardi (F)

Medical Oncology Unit, Azienda Unità Sanitaria Locale, IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy.

Stefano Madrigali (S)

Medical Oncology Unit, Azienda Unità Sanitaria Locale, IRCCS di Reggio Emilia, 42122 Reggio Emilia, Italy.

Monica Civallero (M)

Department of Surgery, Medicine, Dentistry and Morphological Sciences with Transplant Surgery, Oncology and Regenerative Medicine Relevance, University of Modena and Reggio Emilia, 41124 Modena, Italy.

Luigi Marcheselli (L)

Fondazione Italiana Linfomi (FIL), Department of Oncology and Hematology, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy.

Isabella Marchi (I)

Department of Oncology and Hematology, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy.

Federica Domati (F)

Department of Oncology and Hematology, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy.

Marta Venturelli (M)

Department of Oncology and Hematology, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy.

Elena Barbieri (E)

Department of Oncology and Hematology, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy.

Giovanni Grandi (G)

Department of Obstetrics, Gynecology and Pediatrics, Obstetrics and Gynecology Unit, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy.

Enrico Tagliafico (E)

Department of Medical and Surgical Sciences, University of Modena and Reggio Emilia, 41124 Modena, Italy.
Department of Laboratory Medicine and Pathology, Diagnostic Hematology and Clinical Genomics Unit, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy.
Center for Genome Research University of Modena and Reggio Emilia, 41124 Modena, Italy.

Laura Cortesi (L)

Department of Oncology and Hematology, Azienda Ospedaliero Universitaria di Modena, 41124 Modena, Italy.

Classifications MeSH